Skip to main content
. 2020 Apr 7;4:24. Originally published 2020 Feb 13. [Version 2] doi: 10.12688/gatesopenres.13112.2

Table 1. Stages of implementation of Alere-LAM urine test by country.

Country Does the country have
policies that include
Alere-LAM?
(year of introduction) a
Which National
Program includes
Alere-LAM?
(TB, HIV, both) b
Is Alere- LAM
currently in use? c
Is Alere-LAM
use planned for
the near future?
(prospective year) d
Angola No - No Yes (2019)
Botswana Unclear e (2018) TB No Yes (2019)
Brazil No - No Yes
Cameroon - - No Yes
CAR Yes (2016) Both No Yes (2019)
Chad Yes (2018) TB No Yes
China No - No No
DRC No - Yes Yes
Ethiopia Yes (2017) Both No Yes
Ghana No - No Do not know
Guinea-Bissau No - No No
India Yes f HIV No Yes (2020)
Indonesia No - No Yes
Kenya Yes (2019) Both No Yes
Malawi Yes (2017) Both Yes -
Mozambique No - - -
Myanmar Yes (2017) HIV Yes Yes
Nigeria No - - Yes (2019)
Philippines No - No Yes (2021)
Tanzania No - No No
Thailand No - No No
Uganda Yes (2017) Both Yes -
Zambia Yes (2018) TB No Yes
Zimbabwe Yes (2017) Both Yes -
Number answering
“yes”
10 NA 5 15

Summary of answers given by respondents regarding Alere-LAM test adoption stage. A dash indicates no response. CAR = Central African Republic. DRC = Democratic Republic of Congo. aYears that Alere-LAM test policies were introduced into either the TB or HIV National Programs are listed in brackets as reported by the respondents. bThe questionnaire was limited to Alere-LAM policy inclusion in TB and HIV National Programs. cActual use of the Alere-LAM urine tests is independent of existence of a national policy. dProspective year was included only if reported by respondents. eRespondents gave conflicting responses. fTest is not yet introduced.